Arachidonate transforming and immunomodulating agents: unapproved uses or indications.
Lotti
T M
TM
Department of Dermatology, University of Florence, Italy.
Menchini
G
G
Spallanzani
A
A
Moretti
S
S
Ghersetich
I
I
Bianchi
B
B
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D016718:Arachidonic Acid / Q000378:metabolism*; D016861:Cyclooxygenase Inhibitors / Q000378:metabolism / Q000627:therapeutic use*; D003879:Dermatologic Agents / Q000627:therapeutic use*; D017277:Drug Approval; D004363:Drug Utilization; D015777:Eicosanoids / Q000378:metabolism; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D016859:Lipoxygenase Inhibitors / Q000378:metabolism / Q000627:therapeutic use*; D012871:Skin Diseases / Q000188:drug therapy*; D014481:United States; D014486:United States Food and Drug Administration
D000276:Adjuvants, Immunologic; D016861:Cyclooxygenase Inhibitors; D003879:Dermatologic Agents; D015777:Eicosanoids; D007155:Immunologic Factors; D016859:Lipoxygenase Inhibitors; D016718:Arachidonic Acid